Designing a treatment protocol using myofascial therapy for the treatment of pain and restrictions on mobility in patients with hemophilic arthropathy of the knee and ankle.

Pilot with a small number of patients for assessment the effectiveness and safety of the treatment protocol created.

Randomized clinical trial to assess the effectiveness of treatment with myofascial therapy in patients with hemophilia.

Describe the differences in terms of the dependent variables (range of motion, pain and flexibility) in patients with hemophilia who have carried out the treatment.

Report the relationship between the clinical characteristics of patients and the results obtained after the treatment period.

Phase I pilot study with 5 patients with hemophilia for assessment by myofascial therapy protocol designed for this purpose.

Phase II. Randomized, prospective longitudinal clinical study in patients with hemophilia, to assess the efficacy of an intervention with myofascial therapy.

Inclusion Criteria:

• Patients with a diagnosis of hemophilia A and B.
• Patients older than 18 years.
• Patients with a diagnosis of hemophilic arthropathy of the knee and ankle.
• Patients on prophylactic regimen with FVIII / FIX.

Exclusion Criteria:

• Patients without walking ability.
• Patients with a diagnosis of other congenital coagulopathy (eg von Willebrand disease).
• Patients who have developed antibodies to FVIII / FIX (inhibitors).
• Patients with neurological or cognitive impairments that impede understanding of questionnaires and physical test.
• Patients who have not signed the informed consent document.